Owens & Minor, Inc. (OMI)
NYSE: OMI · Real-Time Price · USD
8.58
+0.08 (0.94%)
At close: Mar 28, 2025, 4:00 PM
8.72
+0.14 (1.58%)
After-hours: Mar 28, 2025, 8:00 PM EDT
Owens & Minor Revenue
In the year 2024, Owens & Minor had annual revenue of $10.70B with 3.55% growth. Owens & Minor had revenue of $2.70B in the quarter ending December 31, 2024, with 1.50% growth.
Revenue (ttm)
$10.70B
Revenue Growth
+3.55%
P/S Ratio
0.06
Revenue / Employee
$461,245
Employees
23,200
Market Cap
662.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.70B | 366.92M | 3.55% |
| Dec 31, 2023 | 10.33B | 378.49M | 3.80% |
| Dec 31, 2022 | 9.96B | 170.16M | 1.74% |
| Dec 31, 2021 | 9.79B | 1.31B | 15.39% |
| Dec 31, 2020 | 8.48B | -730.76M | -7.93% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 88.82B |
| Merck & Co. | 64.17B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.88B |
OMI News
- 4 days ago - Owens & Minor Announces Launch of Senior Secured Notes Offering - Business Wire
- 4 weeks ago - Owens & Minor, Inc. (OMI) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Healthcare Logistics Firm Owens & Minor Reports Better-Than-Expected Q4 Earnings, Plans To Repurchase $100 Million In Shares - Benzinga
- 4 weeks ago - Owens & Minor Reports Fourth Quarter & Full Year Financial Results and Announces Sale Process Underway for Products & Healthcare Services Segment - Business Wire
- 5 weeks ago - Owens & Minor, Inc. (OMI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 5 weeks ago - Bronstein, Gewirtz & Grossman, LLC Encourages Owens & Minor, Inc. (OMI) Shareholders to Inquire about Securities Investigation - Accesswire
- 5 weeks ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Owens & Minor, Inc. (OMI) And Encourages Shareholders to Connect - Accesswire
- 6 weeks ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Owens & Minor, Inc. (OMI) And Encourages Shareholders to Reach Out - Accesswire